Source: Harvard University Gazette
Posted: June 8, 2006
Summary:
Harvard Stem Cell Institute (HSCI) researchers at Harvard and Children's Hospital Boston have been cleared to begin experiments using Somatic Cell Nuclear Transfer (SCNT) to create disease-specific stem cell lines in an effort to develop treatments for a wide range of now-incurable conditions afflicting tens of millions of people.
Commentary: Intense public scrutiny of these experiments, while it could possibly be viewed as being obsessive and intrusive, is necessary to ensure results will be valid. In addition, it could benefit the field of stem cell research and regenerative medicine in the long run by enhancing its' public credibility.
No comments:
Post a Comment